Susceptibility testing quality control studies with fosfomycin tromethamine

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 7, 1997, Pages 538-540

  Fuchs, P C ^a   Barry, A L ^a   Brown, S D ^a  

^a CLINICAL MICROBIOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; FOSFOMYCIN TROMETAMOL;

ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DIFFUSION; DILUTION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; REPRODUCIBILITY; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FOSFOMYCIN; GRAM-POSITIVE COCCI; MICROBIAL SENSITIVITY TESTS; OBSERVER VARIATION; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; STAPHYLOCOCCUS AUREUS; TROMETHAMINE;

EID: 0030804709     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01708240     Document Type: Article

References (10)

1. Barry AL, Brown SD: Antibacterial spectrum of fosfomycin trometamol. Journal of Antimicrobial Chemother-apy 1995, 35: 228-230.
2. Ferrari V, Bonanomi L, Borgia M, Lodola E, Marca G: A new fosfomycin derivative with much improved bioavailability by oral route. Chemiotropia Antimicrobica 1981, 4: 59-63.
3. Borsa F, Leroy A, Fillastre J-P, Godin M, Moulin B: Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults. Antimicrobial Agents and Chemotherapy 1988, 32: 938-941.
4. Greenwood D, Elev AJA: Factors influencing the activity of the trometamol salt of fosfomycin. European Journal of Clinical Microbiology & Infectious Diseases 1986, 5: 29-34.
5. Barry AL, Fuchs PC: In vitro susceptibility testing procedures for fosfomycin tromethamine. Antimicrobial Agents and Chemotherapy 1991, 35: 1235-1238.
6. Andrews JM, Baquero F, Beltran JM, Canton E, Crokaert F, Gobernado M, Gomez-lus R, Loza E, Navarro M, Clay T, Rodriguez A, Vicente MV, Wise R, Yourassowky E: International collaborative study on standardization of bacterial sensitivity to fosfomycin. Journal of Antimicrobial Chemotherapy 1983, 12: 357-361.
7. Barry AL, Pfaller MA, Fuchs PC, Tenover FC, Reller LB, Allen SD: Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine. European Journal of Clinical Microbiology & Infectious Diseases 1993, 12: 352-356.
8. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. NCCLS, Wayne, PA, 1993.
9. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A5. NCCLS, Wayne, PA, 1993.
10. Gavan TL, Jones RN, Barry AL, Fuchs PC, Gerlach EH, Matsen JM, Relier LB, Thornsberry C, Thrupp LD: Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. Journal of Clinical Microbiology 1981, 14: 67-72.